Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corpo... (PRCT)
NasdaqGM: PRCT
· Real-Time Price · USD
21.65
-0.30 (-1.37%)
At close: Aug 14, 2026, 8:00 PM
PROCEPT BioRobotics Corporation (PRCT) Stock Price, Analysis & Data
-1.37% (1D)
No data available
| Bid | n/a |
| Market Cap | 1.23B |
| Revenue (ttm) | 337.34M |
| Net Income (ttm) | -109.75M |
| Beta | 0.89 |
| EPS (ttm) | -1.95 |
| PE Ratio (ttm) | n/a |
| Forward PE | -18.78 |
| P/B (ttm) | 3.64 |
| P/S (ttm) | 3.68 |
| Earnings Date | Nov 4, 2026 |
| Ask | n/a |
| Volume | 750,330 |
| Avg. Volume (20D) | 1,680,153 |
| Open | 22.10 |
| Previous Close | 21.95 |
| Day's Range | 21.40 - 22.10 |
| 52-Week Range | 16.66 - 42.70 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided rob...
Industry Medical Devices
Sector Healthcare
IPO Date Sep 15, 2021
Employees 888
Stock Exchange NasdaqGM
Ticker Symbol PRCT
Financial Performance
In 2025, PROCEPT BioRobotics's revenue was 308.05M, an increase of 37.22% compared to the previous year's 224.5M. Earnings were -95.57M, an increase of 4.55%.
Financial StatementsEarnings Surprise
PROCEPT BioRobotics has released their quarterly earnings on Aug 4, 2026:
PROCEPT BioRobotics Corporation is scheduled to release its earnings on Nov 4, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2